APA

Kabeshova A., Ben Hariz S., Tsakeu E., Benamouzig R. & Launois R. (20160701). Cost-effectiveness analysis of rifaximin-α administration for the reduction of episodes of overt hepatic encephalopathy in recurrence compared with standard treatment in France. : Therapeutic advances in gastroenterology.

Chicago

Kabeshova Anastasiia, Ben Hariz Soumaia, Tsakeu Elyonore, Benamouzig Robert and Launois Robert. 20160701. Cost-effectiveness analysis of rifaximin-α administration for the reduction of episodes of overt hepatic encephalopathy in recurrence compared with standard treatment in France. : Therapeutic advances in gastroenterology.

Harvard

Kabeshova A., Ben Hariz S., Tsakeu E., Benamouzig R. and Launois R. (20160701). Cost-effectiveness analysis of rifaximin-α administration for the reduction of episodes of overt hepatic encephalopathy in recurrence compared with standard treatment in France. : Therapeutic advances in gastroenterology.

MLA

Kabeshova Anastasiia, Ben Hariz Soumaia, Tsakeu Elyonore, Benamouzig Robert and Launois Robert. Cost-effectiveness analysis of rifaximin-α administration for the reduction of episodes of overt hepatic encephalopathy in recurrence compared with standard treatment in France. : Therapeutic advances in gastroenterology. 20160701.